KELLIE LISBY: Open Payments
NPI 1578929204 · SHELBYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 27 payments from 16 companies in 2025. Trend: 2023 $88 · 2024 $209 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $87 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| PFIZER INC. | 3 | $61 |
| Corcept Therapeutics | 2 | $38 |
| ABIOMED | 1 | $34 |
| Exact Sciences Corporation | 2 | $28 |
| Medtronic, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
Products named: HETLIOZ, CAPLYTA, Wegovy, PREVNAR 20, Korlym, Ozempic, Cologuard Collection Kit, MINIMED 780G.
Industry payments across KY — which companies pay providers there.
